Re: the adenoids; I know a child who had chronic sinusitis with constant
antibiotic use.  Adenoids were enlarged and blocking the passage.  The
ENT had them wait til he was older to see if they would shrink enough
not to need surgery.  They didn't, he had them out, has been free of
sinus infections for all the years since.

Good luck.

Susan

Until your child has a CT scan, I think any treatment is guesswork.
Chronic sinusitis has an underlying cause--the infection is
opportunistic.  The bugs invade when the sinuses get blocked--the
question is why are they blocked.

The way to avoid ending up a perpetual sinus sufferer is to NOT get
sidetracked by fighting the immediate infections, but to discover the
underlying causes of sinus blockage.

If the sinuses are sufficiently blocked, antibiotics won't clear the
infection at all no matter how long you taken them.

Aloha  irhone11

...Do a google for serrapeptase or use this link ..
http://vitanetonline.com/affiliate/DRB-00149/68853/  .
its been used in japan and europe over  25 years with great results ..lots
of med studies to support also...Aloha Michael

Serrapeptase and Sinusitis

Due to its inflammatory properties, serrapeptase has been shown in clinical
studies to benefit chronic sinusitis sufferers. In this condition, the mucus
in patients' nasal cavities is thickened and hypersecreted. This thickening
causes mucus to be expelled less frequently. Japanese researchers evaluated
the effects of serratiopeptidase (30 mg/day orally for four weeks) on the
elasticity and viscosity of the nasal mucus in adult patients with chronic
sinusitis. Serratiopeptidase reduced the viscosity of the mucus, improving
the elimination of bronchopulmonary secretions.

Other clinical trials support serrapeptase's ability to relieve the problems
associated with chronic sinusitis. In one study, 140 patients with acute or
chronic ear, nose and throat pathologies were evaluated with either a
placebo or the active serratia peptidase. Patients taking the serrapeptase
experienced a significant reduction in severity of pain, amount of
secretion, purulence of secretions, difficulty in swallowing, nasal
dysphonia, nasal obstruction, anosmia, and body temperature after three to
four days and at the end of treatment. Patients suffering from laryngitis,
catarrhal rhinopharyngitis and sinusitis who were treated with serrapeptase
experienced a significant and rapid improvement of symptoms after 3-4 days.
Physicians assessed efficacy of treatment as excellent or good for 97.3
percent of patients treated with serrapeptase compared with only 21.9
percent of those treated with a placebo.

Respiratory diseases are characterized by increased production of a more
dense mucus modified in viscosity and elasticity. Traditionally, in
respiratory diseases, muco-active drugs are prescribed to reestablish the
physicochemical characteristics of the mucus in order to restore respiratory
function. Some of these drugs, however, cause a functional depletion of
mucus, whereas Serrapeptase alters the elasticity of mucus without depleting
it.

A powerful agent by itself, serrapeptase teamed with antibiotics delivers
increased concentrations of the antimicrobial agent to the site of the
infection. Bacteria often endure a process called biofilm formation, which
results in resistance to antimicrobial agents. In an attempt to prevent this
bacterial immunity, researchers have experimented with various means of
inhibiting biofilm-embedded bacteria. Their search may have ended with
serrapeptase. One study conducted by Italian researchers suggests that
proteolytic enzymes could significantly enhance the activities of
antibiotics against biofilms. Antibiotic susceptibility tests showed that
serratiopeptidase greatly enhances the activity of the antibiotic,
ofloxacin, and that it can inhibit biofilm formation.

Another double-blind randomized study evaluated the effects of administering
the antibiotic cephalexin in conjunction with serrapeptase or a placebo to
93 patients suffering from either perennial rhinitis, chronic rhinitis with
sinusitis or chronic relapsing bronchitis. The serratia peptidase treated
group experienced significant improvement in rhinorrhea, nasal stuffiness,
coryza and improvement of the para-nasal sinus shadows.

Researchers witnessed equally impressive results in the treatment of
infections in lung cancer patients undergoing thoracotomy. Serrapeptase and
cefotiam, an antibiotic with a broad spectrum of activity against both
Gram-positive and Gram-negative microorganisms, were administered to 35
thoracotomy patients with lung cancer. The patients were divided into two
groups. A single dose of cefotiam was administered to the 17 subjects in
Group I. The 18 subjects in Group II received a combination of Cefotiam and
serrapeptase. The level of the antibiotic in the tissues versus the blood
was significantly higher in the serrapeptase group than the single dose
group.

Michael

As others have said, what will make the most difference in the long term is not
paritular short-term treatements, but rather finding the cause and fixing it.

If nothing else turns up on testing (and do test for immune status etc as well
as allegies) then, as a working hypothesis,  assume it is environmental and get
rid of carperts, dust or smoke,  mold and cats.    If the house is sealed up
tight so that gases etc. may be building up, then increase ventilation.  

Check here...

http://www.sinusgroup.org/

;)